West Virginia Board of Pharmacy Meeting Agenda for December 6-7, 2015 (including discussion of Chorulon (HCG) for use in cows and HCG diversion)

Charleston, West Virginia

Sunday, December 6, 2015

5:00 P.M., Board Conference room.

1. Welcome new Board Members; administer Oath of Office; discuss administrative matters for travel reimbursement and per diems.
2. Election of Board Officers and assignment of Complaint committee members and CPE Committee member.
3. Approval of September 27-28, 2015, Board Minutes.
4. Board financial update.
5. Receive and review Complaint Committee disciplinary recommendations.

Recess.  Continue meeting on 12/7/15 at 8:00 a.m., Board Conference Room.

Re-convene Monday, December 7, 2015

Charleston, West Virginia

8:00 A.M., Board Conference room.

 6.  Presentation by Matthew Carroll of Creative Strategies in support of a request to approve the eKIT solution Stat Dispense for use in dispensing first dose medications in a nursing home.

7.  Consider requests for reciprocity/license transfer of pharmacists with prior disciplinary issues of concern:  Marshall Edwards, RPh, marked “No” on application concerning any prior discipline, but was disciplined in Kentucky in 2006

8.  Update on DQSA and DSCSA Wholesale and 3PL licensing from FDA national meeting. 

9.  Requests of Wheeling Hospital Pharmacy and Camden Clark Medical Center for approval of their PT Training Programs. 

 10.  Discuss procedure for staff and board review and approval or rejection of PT and PTT applications for registration with review of criminal history.

 11.  Request of PTT Holly Poe and PIC Stephen Shrewsberry to accept hours earned as PTT prior to Registration of PTT being on record at the Board office, and request of PTT Shannon Fenton for extension of time to test for PT registration.

 12.  Request of PTT James Wasanyi and PTT Mark Wasanyi to accept hours earned as PTT prior to Registration of PTT being on record at the Board office.

13.  Review Application for PT Registration of applicant Kim Fagan.

 14.  Discuss registration of nuclear pharmacy technicians.

 15.  Consider Controlled Substance Recommendations and Naloxone recommendations for upcoming Legislative Session, including:

(a)   Request of Dr. Brad Henry (also RPh) to consider recommending that all single active ingredient pseudoephedrine products be restricted to prescription unless in a conversion resistant form;

(b)   Consider permitting Naloxone to be OTC similar to California and other states.

(c)    Removal of Ioflupane from Schedule II as done by DEA;

(d)   Removal of Naloxegol from Schedule II as done by the DEA;

(e)    Placement of Eluxadoline into Schedule IV as done by the DEA;

(f)    Chorulon (HCG) for use in cows and HCG diversion;

(g)   Review of past recommendations on marijuana; and

(h)   Clarifying that Tramadol HCL be amended to Tramadol per request of State Police Crime Lab.

16.  Consider CSMP software and maintenance license, and provide CSMP update.

17.  Review 2016 NABP District 1 & 2 Meeting planning and progress.

18.  Schedule next regular Board Meeting. 

19.  Any other business.

Adjourn.

source found at: http://www.wvbop.com/index.php?option=com_content&view=article&id=60&Itemid=91